<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-BJWB5PMC</identifier><date>2024</date><creator>Hriberšek, Danila</creator><relation>documents/doc/B/URN_NBN_SI_doc-BJWB5PMC_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BJWB5PMC_001.txt</relation><format format_type="issue">2</format><format format_type="volume">75</format><format format_type="type">article</format><format format_type="extent">str. 185-189</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">234728707</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BJWB5PMC</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">centralni živčni sistem</subject><subject language_type_id="slv">farmacija</subject><subject language_type_id="slv">menjava zdravila</subject><subject language_type_id="slv">multipla skleroza</subject><subject language_type_id="slv">nevrodegenerativna kronična bolezen</subject><subject language_type_id="slv">sodobno zdravljenje</subject><title>Klinični primer-izzivi farmakološkega zdraljenja multiple skleroze</title><title>Clinical case-challenges of pharmacological treatment of multiple sclerosis</title></Record>